Theradiag LISA TRACKER – leaders in Therapeutic Drug Monitoring

Last updated: 15th August, 2019

Theradiag are the market leaders in Therapeutic Drug Monitoring  (TDM) with assays validated and supported by the pharmaceutical industry.

Why use Theradiag LISA TRACKER for Therapeutic Drug Monitoring

  • Unique TDM menu with 12 different kits available for drug and anti-drug antibodies
  • Full coverage of biotherapies used in IBD, but also other chronic inflammatory diseases and oncology
  • Accurate quantitative measurement of drug and anti-drug antibodies
  • Easy-to-use with standardised protocols from sample collection to result interpretation
  • Clinically validated with measurement ranges tailored to induction and maintenance treatment phases
  • Validated on automated platforms (DS2, DSX, Evolis, etc.)
  • Validated on biosimilars
  • Validated and supported by the pharmaceutical industry
  • LISA TRACKER included in a high number of studies and publications

 

Theradiag and the Scientific approach to LISA TRACKER for use in TDM

  • Therapeutic Drug monitoring helps physicians to make rational therapeutic decisions during the course of the disease and to support the proper use of drugs
  • Proactive and reactive TDM during treatment induction and maintenance to maximise the clinical benefits of biotherapies while minimising side effects
  • TDM approach leads to major cost savings in healthcare settings compared to a clinically based approach
  • Update on the latest data available for therapeutic windows for all molecules used in IBD
  • LISA TRACKER is validated in accordance with the 1st WHO international standards


More information on Theradiag LISA TRACKER

Download Brochure >

Contact us for a quote

Contact Us Now >
Go BackGo Back
Top